1. Home
  2. ASTH vs VIR Comparison

ASTH vs VIR Comparison

Compare ASTH & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

HOLD

Current Price

$24.79

Market Cap

996.1M

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.54

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTH
VIR
Founded
1994
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
996.1M
1.0B
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
ASTH
VIR
Price
$24.79
$9.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
8
Target Price
$35.33
$19.63
AVG Volume (30 Days)
571.8K
3.9M
Earning Date
06-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
0.33
N/A
Revenue
$519,907,752.00
$68,556,000.00
Revenue This Year
$26.88
N/A
Revenue Next Year
$10.78
$925.73
P/E Ratio
$75.91
N/A
Revenue Growth
45.90
N/A
52 Week Low
$18.08
$4.16
52 Week High
$34.80
$10.91

Technical Indicators

Market Signals
Indicator
ASTH
VIR
Relative Strength Index (RSI) 58.63 62.18
Support Level $23.37 $4.95
Resistance Level $28.49 $10.91
Average True Range (ATR) 1.35 0.69
MACD 0.82 0.07
Stochastic Oscillator 76.37 62.69

Price Performance

Historical Comparison
ASTH
VIR

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: